Document is current

Any future updates will be listed below

Renoprotective effects of combination therapy with tolvaptan and dapagliflozin in autosomal dominant polycystic kidney disease: a four-case series

Crossref DOI link: https://doi.org/10.1007/s13730-025-00990-7

Published Online: 2025-04-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark